Advisor Group Holdings, Inc. Citius Pharmaceuticals, Inc. Transaction History

Advisor Group Holdings, Inc.

$43.4 Billion
Q1 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Citius Pharmaceuticals, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 932,333 shares of CTXR stock, worth $494,136. This represents 0.0% of its overall portfolio holdings.

Number of Shares

932,333

Previous 932,253 0.01%

Holding current value

$494,136

Previous $708,000 18.5%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$0.6 - $0.9 $48 - $72	80 Added 0.01%	932,333 $839,000
Q4 2023 Feb 12, 2024	BUY	$0.65 - $0.86 $558,900 - $739,468	859,847 Added 1187.54%	932,253 $708,000
Q3 2023 Nov 13, 2023	BUY	$0.65 - $1.25 $20,606 - $39,628	31,703 Added 77.89%	72,406 $49,000
Q2 2023 Aug 10, 2023	BUY	$1.08 - $1.65 $1,137 - $1,737	1,053 Added 2.66%	40,703 $48,000
Q1 2023 May 12, 2023	SELL	$0.78 - $1.42 $4,680 - $8,520	-6,000 Reduced 13.14%	39,650 $46,000

Q4 2022 Feb 10, 2023	BUY	$0.79 - $1.23 $7,110 - $11,070	9,000 Added 24.56%	45,650 $36,000
Q3 2022 Nov 14, 2022	BUY	$0.14 - $1.33 $280 - $2,660	2,000 Added 5.77%	36,650 $44,000
Q1 2022 May 04, 2022	SELL	$1.38 - $1.89 $4,140 - $5,670	-3,000 Reduced 7.97%	34,650 $62,000
Q3 2021 Nov 05, 2021	SELL	$1.74 - $2.6 $4,959 - $7,410	-2,850 Reduced 7.04%	37,650 $76,000
Q2 2021 Aug 02, 2021	SELL	$1.51 - $4.23 $50,585 - $141,705	-33,500 Reduced 45.27%	40,500 $141,000
Q1 2021 May 13, 2021	BUY	$1.04 - $2.34 $22,360 - $50,310	21,500 Added 40.95%	74,000 $131,000
Q4 2020 Feb 10, 2021	BUY	$0.9 - $1.2 $42,750 - $57,000	47,500 Added 950.0%	52,500 $54,000
Q3 2020 Nov 12, 2020	BUY	$0.83 - $1.51 $4,150 - $7,550	5,000 New	5,000 $5,000
Q2 2020 Aug 14, 2020	SELL	$0.65 - $1.45 $650 - $1,450	-1,000 Closed	0 $0
Q1 2020 May 18, 2020	BUY	$0.46 - $1.3 $460 - $1,300	1,000 New	1,000 $1,000

Others Institutions Holding CTXR

# of Institutions

Shares Held

26.8M

Call Options Held

Put Options Held

View Full List

About Citius Pharmaceuticals, Inc.

Ticker CTXR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,130,000
Market Cap $77.4M
Description
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...

More about CTXR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Citius Pharmaceuticals, Inc. Transaction History